Correlation Between Software Acquisition and Avadel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Software Acquisition and Avadel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Software Acquisition and Avadel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Software Acquisition Group and Avadel Pharmaceuticals PLC, you can compare the effects of market volatilities on Software Acquisition and Avadel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Software Acquisition with a short position of Avadel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Software Acquisition and Avadel Pharmaceuticals.
Diversification Opportunities for Software Acquisition and Avadel Pharmaceuticals
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Software and Avadel is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Software Acquisition Group and Avadel Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avadel Pharmaceuticals and Software Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Software Acquisition Group are associated (or correlated) with Avadel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avadel Pharmaceuticals has no effect on the direction of Software Acquisition i.e., Software Acquisition and Avadel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Software Acquisition and Avadel Pharmaceuticals
Assuming the 90 days horizon Software Acquisition Group is expected to generate 4.12 times more return on investment than Avadel Pharmaceuticals. However, Software Acquisition is 4.12 times more volatile than Avadel Pharmaceuticals PLC. It trades about 0.23 of its potential returns per unit of risk. Avadel Pharmaceuticals PLC is currently generating about -0.17 per unit of risk. If you would invest 0.82 in Software Acquisition Group on October 25, 2024 and sell it today you would earn a total of 0.68 from holding Software Acquisition Group or generate 82.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 94.44% |
| Values | Daily Returns |
Software Acquisition Group vs. Avadel Pharmaceuticals PLC
Performance |
| Timeline |
| Software Acquisition |
| Avadel Pharmaceuticals |
Software Acquisition and Avadel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Software Acquisition and Avadel Pharmaceuticals
The main advantage of trading using opposite Software Acquisition and Avadel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Software Acquisition position performs unexpectedly, Avadel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avadel Pharmaceuticals will offset losses from the drop in Avadel Pharmaceuticals' long position.| Software Acquisition vs. TRI Pointe Homes | Software Acquisition vs. Southern Home Medicl | Software Acquisition vs. WPP PLC ADR | Software Acquisition vs. Franklin Street Properties |
| Avadel Pharmaceuticals vs. Neurocrine Biosciences | Avadel Pharmaceuticals vs. Ironwood Pharmaceuticals | Avadel Pharmaceuticals vs. Alkermes Plc | Avadel Pharmaceuticals vs. Intracellular Th |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |